Global Automated CPR Devices Market Is Anticipated To Witness High Growth Owing To Increasing Cases Of Chronic Diseases And Growing Geriatric Population

 

Automated CPR Devices Market

Overview:

The use of Automated CPR Devices enables medical personnel to focus their attention on other lifesaving procedures and the patient’s condition, rather than manually performing chest compressions. Automatic mechanical CPR devices have shown to improve hemodynamic variables in porcine and human studies. They have also been shown to increase survival rates in out-of-hospital cardiac arrest (OHCA) and have demonstrated equal performance to high quality manual CPR with an impedance threshold device, while reducing rescuer fatigue. These devices are designed to be used along with automated external defibrillators (AEDs) in cases of sudden cardiac arrest. They provide hands-free chest compressions at a consistent rate, depth and rhythm. They also allow medical personnel to concentrate on other vital steps in the resuscitation process such as administering oxygen, clearing airways and using an AED.

The Global Automated CPR Devices Market Was Valued At US$ 83.5 Mn In 2019 And Is Forecast To Reach A Value Of US$ 196.0 Mn By 2027 At A CAGR Of 11.3% Between 2020 And 2027.

Market Dynamics:

Rising acquisitions y key players is estimated to augment growth of the global Automated CPR Devices Market over the forecast period. For instance, a US-based company Cardio Partners, Inc., acquired Allied 100, LLC, in September 2021, for an undisclosed amount. With this acquisition Cardio Partners and Allied will offer enhanced sudden cardiac arrest (SCA) solutions, training, and services. Moreover, rising cost and lack of trained medical professionals is anticipated to restrain growth of the global automated CPR devices market over the forecast period.

Impact of COVID-19:

The pandemic was first reported in China, in 2019. This outbreak was transmitted to other nations and it had a devastating impact on the growth of many industries. The pandemic also ruptured the global economy. Many companies had to impose strict lockdown restrictions for preventing the transmission of the virus. Manufacturing activities were halt across the globe. Automobile, chemicals, pharmaceuticals, electronic, semiconductors and many other industries were facing shortages of raw materials. However, there was an increase in demand for automated CPR devices, as several people affected with COVID-19 were having trouble breathing. Many individuals were admitted to ICU. Thus, the pandemic had a positive impact on the global automated CPR devices market.

Key Takeaways:

The global Automated CPR Devices Market is expected to witness high significant growth, exhibiting CAGR of 11.3 % over the forecast period, due to increasing product launches. For instance, a Restart Heart Foundation was launched by the Kauvery Hospital, in September 2022. Automated external defibrillators have installed been installed by the foundation for treating people experiencing sudden cardiac arrest.

North America is anticipated to witness significant growth in the global automated CPR devices market over the forecast period, due to growing favorable regulatory framework and increasing geriatric population.

Key players operating in the global automated CPR devices market are SunLife Sciences., ZOLL Medical Corporation, Stryker, CPR Medical Devices, Inc, CPR Medical Devices, Inc, SunLife Sciences., Medkm Healthcare, Jolife AB, Medtronic, Michigan Instruments., Zeal Medical Private Limited, Phoenix Medical Systems Pvt. Ltd, Premier Medical Systems & Devices Private Limited, Technocare Medisystems., Health Care Needs, Universe Surgical Equipment Co., and Summit Healthcare Private Limited.